PULSESIGHT THERAPEUTICS
LIVE

Serial Number

79401614

Owner

PULSESIGHT THERAPEUTICS

Attorney

Ronald M. Kachmarik

Filing Date

Apr 23, 2024

Add to watchlist:

No watchlists yet
View on USPTO

PULSESIGHT THERAPEUTICS Trademark

Serial Number: 79401614 • Registration: 7910162

PULSESIGHT THERAPEUTICS is a trademark filed by PULSESIGHT THERAPEUTICS on April 23, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

PULSESIGHT THERAPEUTICS (2 trademarks)

BIOPARK BATIMENT B, 11, rue Watt

Entity Type: 34

Trademark Details

Filing Date

April 23, 2024

Registration Date

August 26, 2025

Published for Opposition

June 10, 2025

Goods & Services

Medical services; health care; medical services in the field of ophthalmology and eye health.

Pharmaceuticals for the diagnostic and treatment of ophtalmic diseases; chemical-pharmaceuticals for the diagnostic and treatment of ophtalmic diseases; chemical products, biochemical products, biotechnological products for medical, pharmaceutical and veterinary purposes, namely, chemical reagents; biological, chemical, biochemical and biotechnological preparations for medical or pharmaceutical purposes, for the diagnosis and treatment of ocular disorders.

Surgical apparatus and instruments; medical apparatus and instruments, namely electro-transfection delivery medical devices and medical injection devices, associated or not, for ophthalmic applications; ophthalmic surgical apparatus and instruments.

Medical research; medical and scientific research in the field of retinal medicine and treatments; medical and scientific research in the field of eye health; medical research in the field of ophthalmology; scientific research for medical purposes in the area of ophthalmology; scientific research for medical purposes in the area of retinal and ophthalmologic diseases and conditions; scientific research for medical purposes in the area of retinal and ophthalmologic treatments and pharmaceuticals; pharmaceutical research and development; pharmaceutical research and development for retinal and ophthalmologic diseases and conditions; pharmaceutical research and development for improving eye health.

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 2, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 13, 2026 FICS
FINAL DISPOSITION PROCESSED
Mar 13, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 22, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 7, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 7, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 26, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 26, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 26, 2025 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
Jun 19, 2025 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 10, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 10, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 4, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 9, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 6, 2025 TROA
REFUSAL PROCESSED BY IB
Dec 7, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 19, 2024 RFCS
REFUSAL PROCESSED BY MPU
Nov 19, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 14, 2024 RFCR
NON-FINAL ACTION WRITTEN
Nov 13, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 6, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 8, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 8, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 8, 2024 REPR